{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T10:07:11Z","timestamp":1793614031727,"version":"4.5.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T00:00:00Z","timestamp":1683158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Based on cross-sectional studies, there is a link between body composition parameters and steatosis in non-alcoholic fatty liver disease (NAFLD). However, whether long-term changes in different body composition parameters will result in NAFLD resolution is unclear. Therefore, we aimed to summarize the literature on longitudinal studies evaluating the association between NAFLD resolution and body composition change.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Based on the recommendations of the Cochrane Handbook, we performed a systematic search on September 26th, 2021, in three databases: Embase, MEDLINE (via PubMed), and Cochrane Central Register of Controlled Trials (CENTRAL). Eligible studies reported on patients with NAFLD (liver fat &amp;gt;5%) and examined the correlation between body composition improvement and decrease in steatosis. We did not have pre-defined body composition or steatosis measurement criteria. Next, we calculated pooled correlation coefficient (<jats:italic>r<\/jats:italic>) with a 95% confidence interval (CI). Furthermore, we narratively summarized articles with other statistical methods.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We included 15 studies in our narrative review and five in our quantitative synthesis. Based on two studies with 85 patients, we found a pooled correlation coefficient of <jats:italic>r<\/jats:italic> = 0.49 (CI: 0.22\u20130.69, Spearman's correlation) between the change of visceral adipose tissue and liver steatosis. Similarly, based on three studies with 175 patients, the correlation was <jats:italic>r<\/jats:italic> = 0.33 (CI: 0.19\u20130.46, Pearson's correlation). On the other hand, based on two studies with 163 patients, the correlation between subcutaneous adipose tissue change and liver steatosis change was <jats:italic>r<\/jats:italic> = 0.42 (CI: 0.29\u20130.54, Pearson's correlation). Furthermore, based on the studies in the narrative synthesis, body composition improvement was associated with steatosis resolution.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Based on the included studies, body composition improvement may be associated with a decrease in liver fat content in NAFLD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p>Identifier: CRD42021278584.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1114836","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T04:15:01Z","timestamp":1683173701000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Improved body composition decreases the fat content in non-alcoholic fatty liver disease, a meta-analysis and systematic review of longitudinal studies"],"prefix":"10.3389","volume":"10","author":[{"given":"D\u00f3ra","family":"M\u00e1tis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Hegyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitta","family":"Teutsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Tornai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1lint","family":"Er\u0151ss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"P\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szil\u00e1rd","family":"V\u00e1ncsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"Clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.3748\/wjg.v24.i30.3361","article-title":"Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis","volume":"24","author":"Leoni","year":"2018","journal-title":"World J Gastroenterol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","article-title":"Current and future pharmacological therapies for NAFLD\/NASH","volume":"53","author":"Sumida","year":"2018","journal-title":"J Gastroenterol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA."},{"key":"B6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1136\/gut.2011.242073","article-title":"Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss","volume":"60","author":"Hallsworth","year":"2011","journal-title":"Gut."},{"key":"B8","doi-asserted-by":"publisher","first-page":"E454","DOI":"10.1152\/ajpendo.00203.2004","article-title":"Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance","volume":"288","author":"Kabir","year":"2005","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"B9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12072-019-09964-1","article-title":"Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"14","author":"Cai","year":"2020","journal-title":"Hepatol Int."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.3390\/jcm8122175","article-title":"Reduction of fat to muscle mass ratio is associated with improvement of liver stiness in diabetic patients with non-alcoholic fatty liver disease","volume":"8","author":"Osaka","year":"2019","journal-title":"J Clin Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/hep.30049","article-title":"Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a 7-year longitudinal study","volume":"68","author":"Kim","year":"2018","journal-title":"Hepatology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ."},{"key":"B13","doi-asserted-by":"crossref","DOI":"10.1002\/9781119536604","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"},{"key":"B14","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann Intern Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res Synth Methods"},{"key":"B16","unstructured":"R: A language and environment for statistical computing2021"},{"key":"B17","doi-asserted-by":"crossref","DOI":"10.1201\/9781003107347","volume-title":"Doing Meta-Analysis With R: A Hands-On Guide","author":"Harrer","year":"2021"},{"key":"B18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1057\/jt.2009.5","article-title":"The correlation coefficient: its values range between +1\/\u22121, or do they?","volume":"17","author":"Ratner","year":"2009","journal-title":"J Target Meas Anal Mark."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e00316","DOI":"10.14309\/ctg.0000000000000316","article-title":"Moderate-intensity aerobic vs resistance exercise and dietary modification in patients with nonalcoholic fatty liver disease: a randomized clinical trial","volume":"12","author":"Charatcharoenwitthaya","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1042\/CS20150447","article-title":"Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease","volume":"130","author":"Cuthbertson","year":"2016","journal-title":"Clin Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.cgh.2016.07.031","article-title":"Exercise reduces liver lipids and visceral adiposity in patients with nonalcoholic steatohepatitis in a randomized controlled trial","volume":"15","author":"Houghton","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1111\/j.1572-0241.2005.41334.x","article-title":"One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study","volume":"100","author":"Huang","year":"2005","journal-title":"Am J Gastroenterol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jhep.2015.02.022","article-title":"Effect of aerobic exercise training dose on liver fat and visceral adiposity","volume":"63","author":"Keating","year":"2015","journal-title":"J Hepatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"6649142","DOI":"10.1155\/2021\/6649142","article-title":"Metabolic and hepatic effects of energy-reduced anti-inflammatory diet in younger adults with obesity","volume":"2021","author":"Kendel Jovanovi\u0107","year":"2021","journal-title":"Can J Gastroenterol Hepatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.dld.2017.12.014","article-title":"Effect of longitudinal changes of body fat on the incidence and regression of nonalcoholic fatty liver disease","volume":"50","author":"Kim","year":"2018","journal-title":"Dig Liver Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00535-007-2107-z","article-title":"The impact of visceral fat in nonalcoholic fatty liver disease: cross-sectional and longitudinal studies","volume":"42","author":"Koda","year":"2007","journal-title":"J Gastroenterol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1002\/lt.26071","article-title":"Reduction of visceral adiposity as a predictor for resolution of nonalcoholic fatty liver in potential living liver donors","volume":"27","author":"Lee","year":"2021","journal-title":"Liver Transpl."},{"key":"B28","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jhep.2021.02.037","article-title":"Muscle fat content is strongly associated with NASH: a longitudinal study in patients with morbid obesity","volume":"75","author":"Nachit","year":"2021","journal-title":"J Hepatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/oby.21890","article-title":"Differential impact of weight loss on nonalcoholic fatty liver resolution in a North American cohort with obesity","volume":"25","author":"Rachakonda","year":"2017","journal-title":"Obesity."},{"key":"B30","doi-asserted-by":"publisher","first-page":"495","DOI":"10.2147\/DMSO.S185705","article-title":"Progressive reduction in skeletal muscle mass to visceral fat area ratio is associated with a worsening of the hepatic conditions of non-alcoholic fatty liver disease","volume":"12","author":"Shida","year":"2019","journal-title":"Diabetes Metab Syndr Obes."},{"key":"B31","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.1055\/s-0042-117875","article-title":"Simple resistance exercise for 24 weeks decreases alanine aminotransferase levels in patients with non-alcoholic fatty liver disease","volume":"1","author":"Takahashi","year":"2017","journal-title":"Sports Med Int Open."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.3390\/biomedicines9101346","article-title":"Non-alcoholic fatty liver disease in lean and non-obese individuals: current and future challenges","volume":"9","author":"Kuchay","year":"2021","journal-title":"Biomedicines."},{"key":"B33","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.cgh.2015.07.024","article-title":"Body fat distribution and risk of incident and regressed nonalcoholic fatty liver disease","volume":"14","author":"Kim","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.1210\/jc.2015-2649","article-title":"Sex-specific differences in hepatic fat oxidation and synthesis may explain the higher propensity for NAFLD in men","volume":"100","author":"Pramfalk","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.3389\/fphys.2019.01486","article-title":"Why do men accumulate abdominal visceral fat?","volume":"10","author":"Nauli","year":"2019","journal-title":"Front Physiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"414","DOI":"10.14218\/JCTH.2020.00065","article-title":"Skeletal muscle dysfunction in the development and progression of nonalcoholic fatty liver disease","volume":"8","author":"Altajar","year":"2020","journal-title":"J Clin Transl Hepatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12986-020-00511-6","article-title":"Effectiveness of companion-intensive multi-aspect weight management in Chinese adults with obesity: a 6-month multicenter randomized clinical trial","volume":"18","author":"Jiang","year":"2021","journal-title":"Nutr Metab."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1038\/oby.2005.228","article-title":"Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society","volume":"13","author":"Villareal","year":"2005","journal-title":"Obes Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.jhep.2022.04.002","article-title":"Breakthroughs in therapies for NASH and remaining challenges","volume":"76","author":"Ratziu","year":"2022","journal-title":"J Hepatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/s41591-021-01458-8","article-title":"Accelerating the translational medicine cycle: the Academia Europaea pilot","volume":"27","author":"Hegyi","year":"2021","journal-title":"Nat Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3390\/jcm9051532","article-title":"Academia Europaea position paper on translational medicine: the cycle model for translating scientific results into community benefits","volume":"9","author":"Hegyi","year":"2020","journal-title":"J Clin Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1114836\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T04:15:05Z","timestamp":1683173705000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1114836\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,4]]},"references-count":41,"alternative-id":["10.3389\/fmed.2023.1114836"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1114836","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,4]]},"article-number":"1114836"}}